SUPPLY AGREEMENTSupply Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
[*****] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
TO GLOBAL MASTER SERVICES AGREEMENT AND TO SUPPLY AGREEMENTGlobal Master Services Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
This Amendment (“2017 Amendment”) to the Global Master Services Agreement dated 1 January 2015 (“MSA”) and the Supply Agreement dated 1 January 2016 (“Supply Agreement”) is entered into as of 3 May, 2017 (“2017 Amendment Effective Date”) by and between
Global Master Services AgreementGlobal Master Services Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
[*****] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
TO GLOBAL MASTER SERVICES AGREEMENT AND TO SUPPLY AGREEMENTMaster Services Agreement • December 18th, 2018 • Centogene B.V. • Services-medical laboratories
This Amendment (“2019 Amendment”) to the Global Master Services Agreement dated 1 January 2015 (“MSA”) and the Supply Agreement dated 1 January 2016 (“Supply Agreement”) is entered into as of 2 July, 2018 by and between
DEED OF ISSUE CENTOGENE N.V.Centogene B.V. • December 18th, 2018 • Services-medical laboratories
Centogene N.V., a public company with limited liability, having its corporate seat in Amsterdam (address: Am Strande 7, 18055 Rostock, Germany, trade register number: 72822872) (the “Company”).
